Reborn Redx Inks Global Licensing Deal With AstraZeneca

AZ Buys Rights To Porcupine Inhibitor For Fibrotic Diseases

 
• By Sten Stovall
  
Signpost
Redx Has Come A Long Way Since Exiting Insolvency In 2017 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business